Search company, investor...
NanoImaging Services company logo

NanoImaging Services

Founded Year



Grant | Alive

Total Raised


Last Raised

$200K | 13 yrs ago

About NanoImaging Services

NanoImaging Services aims to provide transmission electron microscopy (TEM) imaging and analysis services to the pharmaceutical, biotechnology and nanotechnology industries.

Headquarters Location

10931 North Torrey Pines Road Suite 108

La Jolla, California, 92037,

United States


Missing: NanoImaging Services's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NanoImaging Services's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest NanoImaging Services News

NanoImaging Services Collaborates with Viva Biotech to Offer an Integrated CryoEM Gene-to-Structure Workflow to Streamline Target Discovery

Oct 13, 2021

Search jobs 12-Oct-2021 NanoImaging Services Collaborates with Viva Biotech to Offer an Integrated CryoEM Gene-to-Structure Workflow to Streamline Target Discovery SAN DIEGO, CA – (October 12, 2021) – NanoImaging Services, Inc., the premier industry provider of cryoEM services, microscope access and training, and Viva Biotech Holdings, a leading open-access and innovation-driven technology platform company, have announced a partnership agreement to develop a streamlined, cryoEM enabled gene-to-structure workflow, to ultimately accelerate medicinal chemistry analysis. This strategic partnership will bring together NanoImaging Services’ industry-leading expertise and innovation in high-resolution structural enablement by cryoEM and Viva Biotech’s world leading drug discovery platform to enable the management of projects from construct design through to final maps and subsequent protein supply, and analyses for medicinal chemistry cycles. This seamlessly integrated workflow will facilitate target and structure validation for companies with challenging targets in an efficient and cost-effective manner, streamlining drug discovery pipelines and ultimately reducing the time to clinic. Giovanna Scapin, Ph.D., Chief Scientific Officer at NanoImaging Services said, “One of the strongest predictors of success in structural enablement of drug discovery targets is the purity, homogeneity, and in-depth biochemical and biophysical characterization of the reagents involved. This agreement utilizes our industry-leading expertise and innovation in high-resolution structural enablement by cryoEM, partnered with a worldwide leader in protein production and characterization. Together we aim to successfully target the most complex and challenging projects in drug discovery for our shared clients in a cost- and time- effective manner.” “We are very excited to build the strategic cooperation with NanoImaging Services,” said Dr. Ren Delin, Executive Director and President of Viva. “NanoImaging Services, the world's top cryoEM service provider, has considerable advantages in technology and equipment. As the world's leading drug discovery platform, Viva has efficient protein purification and production capabilities, along with the advanced membrane protein expression and screening technology. Our cooperation is expected to further enhance the ability of target discovery, to empower the clients to develop new drugs as soon as possible, and benefit more patients.” said Dr. Ren Delin, Executive Director and President of Viva Biotech. By combining forces and aligning these already successful and proven workflows, target enablement and medicinal chemistry timelines can be shortened significantly. This, along with the increased success rates, can contribute to bringing down the overall investment costs and creating a more efficient workflow. To find out more about NanoImaging Services cryoEM solutions for protein structure determination, please visit our website here . About NanoImaging Services NanoImaging Services, Inc. launched in 2007 to provide imaging services to the pharmaceutical, biotechnology and nanotechnology communities. We have since built a client-focused organization with a reputation for expertise, reliability and collaboration. NIS is committed to expanding our service capacity through microscope acquisition, workflow automation, recruitment and training of top talent, and development of new service offerings. Our state-of-the-art facilities include a range of electron microscopes, sample preparation equipment and computational infrastructure to support structural biology, nanoparticle characterization and chemistry workflows. With recent acquisitions, NIS has become the largest and most comprehensive provider of TEM, cryoEM and microED services to the industrial life science market. For more information, visit: . About Viva Biotech Holdings Since its establishment in 2008, Viva Biotech (01873.HK) has always been adhering to the mission of "Becoming the cradle of global innovative biotech companies from around the world" and provided one-stop services for drug R&D and production to global biopharmaceutical innovators. Leveraging the technical advantages in the field of Structure-based Drug Discovery (SBDD), we provide leading CRO drug discovery services and CMC / CDMO services throughout the whole drug production process to global biopharmaceutical clients. At the same time, we focus on finding and investing in high potential biotech start-ups, solve unmet clinical medical needs in the form of EFS (service for equity), and continue to build an open cooperation platform and win-win ecosystem for biotech innovation. As of June 30, 2021, Viva Biotech has provided drug R&D and production services to 1,695 biotech and pharmaceutical clients around the world. We have invested and incubated 75 biotech start-ups in total. In the future, the Company will continue to strengthen its technical barriers, improve R&D and production level, and the service capacity, so as to provide high-quality and diversified services for more drug discovery start-ups, as well as the medium and large pharmaceutical enterprises around the world. We hope to benefit more patients through Viva’s platform.

NanoImaging Services Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

NanoImaging Services Rank

NanoImaging Services Frequently Asked Questions (FAQ)

  • When was NanoImaging Services founded?

    NanoImaging Services was founded in 2007.

  • Where is NanoImaging Services's headquarters?

    NanoImaging Services's headquarters is located at 10931 North Torrey Pines Road, La Jolla.

  • What is NanoImaging Services's latest funding round?

    NanoImaging Services's latest funding round is Grant.

  • How much did NanoImaging Services raise?

    NanoImaging Services raised a total of $1.7M.

  • Who are the investors of NanoImaging Services?

    Investors of NanoImaging Services include National Institutes of Health and Merck Capital Ventures.

  • Who are NanoImaging Services's competitors?

    Competitors of NanoImaging Services include MOgene LC, Array Biopharma, Algaen, SweTree Technologies, PKPD and 11 more.

Compare NanoImaging Services to Competitors

Angel Biotechnology

Angel Biotechnology Holdings PLC (AIM: ABH) is a world class, contract biomanufacturing company offering process development services and pre-GMP and cGMP manufacturing to support biotechnology and pharmaceutical companies worldwide. Angel's principal activity is the manufacture and supply of materials for use in early stage drug development and pre-clinical studies, along with drug product and CMC documentation for Phases I, II and III clinical trials and the manufacture of licensed drugs or vaccines. nnAngel is managed by a team that has more than 100 years' combined experience in pharmaceutical and biopharmaceutical manufacture, gained in companies such as Glaxo and Serologicals Inc. nnAngel operates out of Pentlands Science Park, near Edinburgh.

Genicon Sciences Corporation

Genicon Sciences Corporation (Now part of Invitrogen) Genicon Sciences is a company providing assay solutions to the biotechnology, genomics, proteomics and clinical diagnostics industries. The company's Resonance Light Scattering (RLS) technology is a patented, ultra-sensitive signal generation platform for the simple and efficient detection, measurement and analysis of biological interactions. RLS technology aims to utilize the Resonance Light Scattering properties of nano-size particles that can be used on various test formats including microarray, microfluidics, membranes and HTS formats.

Plexus Ventures Logo
Plexus Ventures

The company provide business development services to clients in the pharmaceutical, biotechnology, consumer health, and drug delivery industries worldwide. The company's team members represent an array of nationalities and a mix of commercial, manufacturing, medical, and scientific expertise, gained from decades of experience with both global pharmaceutical and development-stage companies


ITER S.r.l. offers its services to businesses and Public Administrations as a partner in developing customised projects and services "from the strategy to the secretariat. Since 1989 the company have been organising b2b events about topics such as:nnElectronic document and corporate information management -u003Eu003E OMATnOMAT: a edition programmennFront office -u003Eu003E VoiceComnnBiotechnologies -u003Eu003E BioforumnnNanotechnologies -u003Eu003E NanoforumnnIt has a database - consolidated and highly qualified - of over 110,000 names of people working in different sectors. It also has over 4,000 contacts - with the number growing constantly and rapidly - in the biotechnologies and nanotechnologies sectors;nnIt works successfully with businesses, associations, public bodies and authorities in the IT, Biotechnologies and Nanotechnologies sectors, spreading knowledge of solutions and services through the organisation of specialised seminars;nnIts aim is to be a meeting point between demand and supply in the CTI market through the publication of quarterly magazines (information on electronic document management) and VoiceCom news (focused on customer relations management);nnIt edits books, handbooks and does market research on topical issues, availing itself of qualified experts;nnIt disseminates knowledge of topics connected with CTI and biotechnologies through newsletters ITERnews and Bioforumnews.


SiTec Consulting was established in 1996, on the basis of long experience in pharmaceutical R&D. The company developed a range of expertise working with pharmaceutical and biotech companies in the United States and in Europe.n SiTec Consulting offers pharmaceutical and biotechnology companies a variety of services in the areas of preformulation, drug development, drug delivery and formulation technologies evaluation, regulatory and cGLP/cGMP compliance. The company can actively collaborate with start-up pharmaceutical and drug delivery companies to provide scientific and strategic support in the establishment of the new company's activities. The company emphasize open communication, active involvement with the client and continuous feedback.n Networking is one of the company's assets, allowing us to cover the complex demands of the R&D process. The company have access to laboratories and equipment and resources, located at the Bioindustry Park Canavese, and at selected universities and research centers in Europe. This aims to give the possibility to conduct and manage experimental parts of projects at the company's clients' request.n The company value the importance of high quality training. In addition to the hands-on experience the company can provide to the company's clients, SiTec is an authorized representative of the Center for Professional Advancement, a worldwide private institution dedicated to the provision of continuing technical and scientific education at a professional level.

Triacle Biocomputing Logo
Triacle Biocomputing

Triacle Biocomputing Is A Software Development Company Serving The Life Science, Biomedical And Biotechnology Sector.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.